vaccinejihad
chemotherapy
medicalextremism
dangerousmedicine
medicalviolence
bigpharmanews
News & Articles By Cassie B.
07/28/2025
/
By Cassie B.
Kaiser Permanente halts youth gender surgeries amid federal scrutiny but keeps pushing puberty blockers
Kaiser Permanente pauses gender-reassignment surgeries for minors under 19, citing federal regulatory changes under Trump’s executive order. The healthcare provider will continue offering puberty blockers and cross-sex hormones, drawing criticism for prioritizing profits over patient safety. Trump’s order cuts federal funding for underage medical transitions and investigates potential Medicaid fraud by gender clinics. Detransitioner Chloe […]
07/28/2025
/
By Cassie B.
Popular diabetes and weight loss drug doubles risk of eye disease that causes blindness, study warns
Popular diabetes and weight-loss drug tirzepatide (Mounjaro/Zepbound) more than doubles the risk of severe eye disease, with 1.1% of users developing sight-threatening retinopathy compared to 0.5% of non-users. The study tracked 6,870 Type 2 diabetes patients, revealing a 115% higher risk of proliferative diabetic retinopathy (PDR), which can cause blindness if untreated. Rapid blood sugar […]
07/14/2025
/
By Cassie B.
Federal jury awards $4 million to St. Louis school employees denied religious vaccine exemptions
A federal jury awarded over $4 million to 13 St. Louis school employees denied religious exemptions from a COVID-19 vaccine mandate. The plaintiffs sued for violations of First Amendment rights and religious discrimination, with the jury awarding punitive damages. Not a single religious exemption was granted by the district, while medical exemptions were approved case-by-case. […]
07/10/2025
/
By Cassie B.
Judge slams CVS’ Omnicare with $949 million penalty for decade-long prescription fraud
A federal judge ordered CVS’s Omnicare to pay $948.8M for fraudulently billing Medicare, Medicaid, and Tricare for invalid prescriptions over nearly a decade. Omnicare bypassed legal safeguards, submitting 3.3M false claims for expired or improperly documented prescriptions, exploiting vulnerable patients in long-term care. The penalty includes $406.8M in tripled damages and a $542M fine under […]
06/26/2025
/
By Cassie B.
RFK Jr. halts U.S. funding for Gavi over vaccine safety concerns
The U.S. will halt funding to Gavi until it implements strict vaccine safety reforms, citing negligence in addressing risks like those linked to the DTP vaccine. Kennedy criticized Gavi for prioritizing universal vaccination over independent safety reviews, aligning with growing skepticism of pharmaceutical influence. Critics warn the funding cut could harm global health, but Kennedy […]
06/12/2025
/
By Cassie B.
Psychiatric drugs linked to higher ALS risk, Swedish study warns
A Swedish study links psychiatric drugs to higher ALS risk—34% for anxiety meds, 26% for antidepressants, and 21% for sedatives. ALS patients on these medications declined faster and had shorter survival times, with antidepressants tied to a 72% higher mortality risk. Researchers suggest psychiatric symptoms or drug mechanisms may trigger neurodegenerative pathways, although causation isn’t […]
06/11/2025
/
By Cassie B.
Wisconsin defies CDC, keeps pushing COVID shots for pregnant women and kids despite safety concerns
Wisconsin defies updated CDC guidance by continuing to recommend COVID-19 vaccines for pregnant women and children as young as six months. The CDC now advises individualized decisions for children and no longer pushes vaccines for pregnant women, citing a lack of new supporting data. Florida praises the CDC’s shift, calling it evidence-based, while Wisconsin faces […]
05/23/2025
/
By Cassie B.
Antidepressants double sudden cardiac death risk, study warns; young adults face five-fold danger
Danish research reveals antidepressants dramatically increase the risk of sudden cardiac death, with young adults facing up to five times the normal risk. Long-term antidepressant use (6+ years) more than doubles SCD risk, while adults aged 30 to 39 are most vulnerable, even without prior heart conditions. The study analyzed 4.3 million people, confirming antidepressants […]
05/07/2025
/
By Cassie B.
Trump halts U.S. funding for dangerous gain-of-function research in China tied to COVID origins
President Trump signed an executive order banning federal funding for gain-of-function research in poorly regulated countries like China, citing risks to public health and national security. The order follows evidence linking U.S.-backed research at the Wuhan Institute of Virology to the COVID-19 pandemic, which caused global devastation. Internal records show NIH and USAID funded risky […]
04/22/2025
/
By Cassie B.
Trump weighs tying U.S. drug prices to cheaper global rates, sparking pharma backlash
President Trump revives a plan to lower U.S. prescription drug prices by tying them to cheaper rates paid in other nations. Americans pay nearly triple for drugs compared to patients abroad. Panicked pharma leaders call the policy an existential threat, warning it could stifle innovation and disrupt the healthcare market. The plan mirrors a 2020 […]
« Previous Page
5 of 29
Next Page »
Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected.
Subscription confirmation required.
Popular Articles
Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Subscription confirmation required.
We respect your privacy
and do not share emails with anyone. You can easily unsubscribe at any time.
COPYRIGHT © 2017 MEDICAL EXTREMISM
Privacy Policy
Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Subscription confirmation required.
We respect your privacy
and do not share emails with anyone. You can easily unsubscribe at any time.
Close
x
By continuing to browse our site you agree to our use of cookies and our
Privacy Policy
.
Agree and close